MKS Instruments (NasdaqGS:MKSI) in our automated value investing analysis, with the cash flow history and price comparison below.
Advertisement helps keep Trendshare free for most readers.
Estimate how long you need to hold MKS Instruments to reach your target.
Based on historical returns, we believe that MKS Instruments can grow its free cash at a rate of about 7%. That's positive!
| Advantages | Disadvantages |
|---|---|
|
|
| MKSI Price (MKS Instruments stock price per share) |
$210.65 | |
|
|
MKSI Fair Price (based on intrinsic value) |
$82.92 |
| MKSI Safety Price (based on a variable margin of safety) | $53.90 | |
|
Try your own return
The fair price above uses a 10.1% discount rate, the long-run US stock return (10.1% geometric, 1926 to 2025, from Bessembinder's working paper, updated 2026-11-09), and 2.5% terminal growth. A higher rate suits a higher return target and gives a lower value. Value per share: |
||
| PE Ratio versus Sector | 51% higher than other Technology stocks | |
| PE Ratio versus Industry | 17% lower than other Scientific & Technical Instruments stocks | |
| Cash Yield | 1.04% | |
| Free Cash Flow Jitter | 39% | |
| Dividend Yield | 0.47% (tax impact) | Shares Shorted | 4,820,004 |
No open-market insider buys or sells are recorded for the last 12 months.
This stock has short interest! This means that people have shorted it.
Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.
As of the latest analysis, there are 4,820,004 shares shorted. With 67,224,895 shares available for purchase and an average trading volume over the past 10 trading days of 1,998,190, it would take at least 2.4 days for all of the short holders to cover their shorts.
Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth
How to read this: free cash flow in plain terms, free cash flow jitter.
Each year names the SEC filer that reported it, so a change of filer shows up here.
| Fiscal year | SEC filer (CIK) | Free cash flow (USD millions) |
|---|---|---|
| 2008 | 1049502 | 79.3 |
| 2009 | 1049502 | -3.9 |
| 2010 | 1049502 | 152 |
| 2011 | 1049502 | 144 |
| 2012 | 1049502 | 124 |
| 2013 | 1049502 | 63 |
| 2014 | 1049502 | 87 |
| 2015 | 1049502 | 124 |
| 2016 | 1049502 | 165 |
| 2017 | 1049502 | 338 |
| 2018 | 1049502 | 386 |
| 2019 | 1049502 | 207 |
| 2020 | 1049502 | 461 |
| 2021 | 1049502 | 574 |
| 2022 | 1049502 | 436 |
| 2023 | 1049502 | 222 |
| 2024 | 1049502 | 420 |
| 2025 | 1049502 | 524 |
Download the yearly data as CSV.
How to read this: what free cash flow is, why earnings matter.
Over the 16 fiscal years from 2008 to 2025 with positive net income, operating cash flow totaled $4,914 million against net income of $3,321 million, or 1.48 times. Net income was negative in 2 of the 18 years, and those years are left out of the ratio.
In 2025, operating cash flow was 2.19 times net income, compared with 1.48 times for the earliest three years (2008 to 2010).
In 2025, capital expenditures were $148 million, 22.9% of operating cash flow of $645 million, which leaves an estimated $497 million after capex. Across the 18 years with reported capex, it averaged 18.5% of operating cash flow. This uses that year's own capital expenditures, not the five-year average behind the free cash flow table, so the two can differ.
| Fiscal year | Net income (USD millions) | Operating cash flow (USD millions) | Capital expenditures (USD millions) | Operating cash flow / net income |
|---|---|---|---|---|
| 2008 | 30.1 | 92.7 | 13.5 | 3.08 |
| 2009 | -213 | 4.9 | 4.2 | n/a |
| 2010 | 143 | 163 | 15.8 | 1.15 |
| 2011 | 130 | 156 | 15.6 | 1.20 |
| 2012 | 48 | 137 | 17.7 | 2.86 |
| 2013 | 35.8 | 76.1 | 12.4 | 2.13 |
| 2014 | 116 | 102 | 13.2 | 0.88 |
| 2015 | 122 | 138 | 12.4 | 1.13 |
| 2016 | 105 | 180 | 19.1 | 1.72 |
| 2017 | 339 | 355 | 31.3 | 1.05 |
| 2018 | 393 | 414 | 62.9 | 1.05 |
| 2019 | 140 | 245 | 63.9 | 1.74 |
| 2020 | 350 | 513 | 85 | 1.47 |
| 2021 | 551 | 640 | 87 | 1.16 |
| 2022 | 333 | 529 | 164 | 1.59 |
| 2023 | -1,841 | 319 | 87 | n/a |
| 2024 | 190 | 528 | 118 | 2.78 |
| 2025 | 295 | 645 | 148 | 2.19 |
How to read this: why companies buy back shares, dividend yield explained.
Over the 10 fiscal years from 2016 to 2025 with dividend or share repurchase facts, estimated free cash flow totaled $3,732 million. That estimate uses the average of up to five years of capital expenditures, not each year's own, so it is not a reported figure.
In the 10 of those years with dividend payment facts, dividends paid totaled $480 million, 12.9% of the estimated free cash flow of those years. Estimated free cash flow was at least the dividends paid in 10 of those 10 years.
In 2 of the 10 years, cash spent repurchasing shares was at least 5% of that year's estimated free cash flow, and in those years it totaled $120 million. Smaller amounts are left out of this sentence because they can be shares withheld to pay employees' taxes on stock awards.
In 2025, dividends and cash spent repurchasing shares together were $104 million, 19.8% of estimated free cash flow of $524 million.
| Fiscal year | Estimated free cash flow (USD millions) | Dividends paid (USD millions) | Cash spent repurchasing shares (USD millions) | Total returned (USD millions) | Total as a percent of estimated free cash flow |
|---|---|---|---|---|---|
| 2016 | 165 | 36.4 | 1.5 | 37.9 | 23.0% |
| 2017 | 338 | 38.2 | n/a | 38.2 | 11.3% |
| 2018 | 386 | 42.4 | 75 | 117 | 30.4% |
| 2019 | 207 | 43.5 | n/a | 43.5 | 21.1% |
| 2020 | 461 | 44 | n/a | 44 | 9.6% |
| 2021 | 574 | 47 | n/a | 47 | 8.2% |
| 2022 | 436 | 52 | n/a | 52 | 11.9% |
| 2023 | 222 | 59 | n/a | 59 | 26.6% |
| 2024 | 420 | 59 | n/a | 59 | 14.1% |
| 2025 | 524 | 59 | 45 | 104 | 19.8% |
Free cash flow here is an estimate: operating cash flow less the average of up to five years of capital expenditures. Cash spent repurchasing shares can include shares withheld to pay employees' taxes on stock awards. The entry n/a means the filings gave no usable figure, not that the amount was zero. Source: the company's annual reports to the SEC.
How to read this: earnings and margins.
Revenue was $621 million in 2008 and $3,931 million in 2025, a compound annual growth rate of 11.5% over 17 years.
Revenue rose 9.6% from 2024 to 2025.
Our estimated free cash flow was $524 million in 2025, 13.3% of revenue. In 2008 the estimated margin was 12.8%. This estimate charges each year with the average of up to five years of capital expenditures, so it is not the free cash flow the company reported.
| Fiscal year | Revenue (USD millions) | Estimated free cash flow (USD millions) | Estimated free cash flow / revenue |
|---|---|---|---|
| 2008 | 621 | 79.3 | 12.8% |
| 2009 | 393 | -3.9 | -1.0% |
| 2010 | 853 | 152 | 17.9% |
| 2011 | 823 | 144 | 17.5% |
| 2012 | 644 | 124 | 19.2% |
| 2013 | 669 | 63 | 9.4% |
| 2014 | 781 | 87 | 11.1% |
| 2015 | 814 | 124 | 15.2% |
| 2016 | 1,295 | 165 | 12.7% |
| 2017 | 1,916 | 338 | 17.6% |
| 2018 | 2,075 | 386 | 18.6% |
| 2019 | 1,900 | 207 | 10.9% |
| 2020 | 2,330 | 461 | 19.8% |
| 2021 | 2,950 | 574 | 19.5% |
| 2022 | 3,547 | 436 | 12.3% |
| 2023 | 3,622 | 222 | 6.1% |
| 2024 | 3,586 | 420 | 11.7% |
| 2025 | 3,931 | 524 | 13.3% |
How to read this: how debt and assets are compared, the current ratio.
In 2025, cash and equivalents were $418 million against total liabilities of $6,077 million, or 6.9% of total liabilities. Total liabilities include everything the company owes, not only borrowed money.
Total liabilities were 69.1% of total assets in 2025, compared with 11.5% in 2009, an increase of 57.6 percentage points.
Stockholders equity was $2,719 million in 2025, compared with $685 million in 2009, a rise of 297.0%.
Based on our estimated free cash flow, cash flow return on invested capital (CROIC) was 7.0% in 2025. Invested capital here is total assets less cash and current liabilities.
| Fiscal year | Total assets (USD millions) | Cash and equivalents (USD millions) | Total liabilities (USD millions) | Stockholders equity (USD millions) |
|---|---|---|---|---|
| 2009 | 774 | 111 | 89.1 | 685 |
| 2010 | 982 | 162 | 135 | 847 |
| 2011 | 1,119 | 313 | 129 | 990 |
| 2012 | 1,153 | 288 | 140 | 1,012 |
| 2013 | 1,213 | 289 | 191 | 1,022 |
| 2014 | 1,224 | 305 | 142 | 1,082 |
| 2015 | 1,273 | 228 | 112 | 1,161 |
| 2016 | 2,212 | 229 | 970 | 1,242 |
| 2017 | 2,414 | 334 | 825 | 1,589 |
| 2018 | 2,614 | 644 | 741 | 1,873 |
| 2019 | 3,416 | 415 | 1,394 | 2,022 |
| 2020 | 3,904 | 608 | 1,544 | 2,360 |
| 2021 | 4,540 | 966 | 1,653 | 2,887 |
| 2022 | 11,495 | 909 | 7,012 | 4,483 |
| 2023 | 9,118 | 507 | 6,646 | 2,472 |
| 2024 | 8,590 | 420 | 6,268 | 2,322 |
| 2025 | 8,796 | 418 | 6,077 | 2,719 |
How to read this: discounted cash flow, intrinsic value.
At today's price of $210.65, our model's value equals that price if free cash flow grows an average of 26.5 percent a year over the 10 projection years. Our model assumes 7.5 percent a year for this stock, so the price implies growth of 26.5 percent, which is above the 7.5 percent our model assumes. This is the growth the price implies under our model, not a forecast of growth or a price target.
At 26.5 percent a year, free cash flow would grow about 10.5 times over the 10 years.
The table shows the same calculation at a price 20 percent lower and 20 percent higher than today's price, and the model's own growth rate at its fair price.
The model starts from the company's average free cash flow of $148 million, grows it over 10 years along the year-by-year growth path stored for this stock (the pace fades over the years, and the implied rate keeps that shape, so the rates here are 10-year averages), discounts it at 10.1 percent a year, adds a terminal value that grows 2.5 percent a year after year 10, adds the company's net worth, and divides by shares outstanding.
The baseline is the company's average free cash flow, and cyclical companies can mislead it.
| Case | Price per share | Average annual free cash flow growth |
|---|---|---|
| 20 percent below the current price | $168.52 | 22.5% |
| Current price | $210.65 | 26.5% |
| 20 percent above the current price | $252.78 | 29.6% |
| Our model (stored fair price) | $82.92 | 7.5% |
Model assumptions: 10.1 percent discount rate, 2.5 percent terminal growth, 10 projection years. To try your own growth rate, use the intrinsic value calculator on this page. It uses a simpler single-rate model, so its results will not match the figures above exactly.
MKS Instruments is priced at $210.65, above our fair value estimate of $82.92 and its safe value of $53.90.
Only 17 of the 18 fiscal years under MKS Instruments's current filer show positive free cash flow.
The latest three years average $389 million in free cash flow against $75.9 million for the earliest three, which is a sharp rise.
Free cash flow is volatile from year to year, with a variability measure of 39%.
These numbers change when new filings or prices arrive, so treat this page as a snapshot and check the company's own filings.
Its dividend yield is 0.47%.
How to read this: the price to earnings ratio.
Its trailing P/E ratio is 51% above the average for stocks in the Technology sector.
Its trailing P/E ratio is 17% below the average for stocks in the Scientific & Technical Instruments industry.
A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.
These are companies in the Scientific & Technical Instruments industry, the ones closest in market capitalization to MKS Instruments, limited to companies whose pages we publish. The figures come from our latest data for each company.
| Company | Market cap (USD millions) | P/E | Dividend yield | Cash yield | Price versus our estimate |
|---|---|---|---|---|---|
| MKS Instruments (MKSI) | 14,244 | 24.9 | 0.5% | 1.0% | 154% above |
| Trimble (TRMB) | 12,365 | - | - | 4.1% | 18% below |
| Avantor (AVTR) | 10,286 | 30.4 | - | - | 85% above |
| Onto Innovation (ONTO) | 9,867 | 66.1 | - | - | 370% above |
| Bruker Corporation (BRKR) | 9,661 | - | 0.1% | - | 293% above |
| Bio-Rad Laboratories (BIO) | 9,633 | 9.5 | - | 0.8% | 9% below |
| Fortive Corporation (FTV) | 19,862 | 31.6 | 0.4% | - | 208% above |
Industry labels are approximate, and companies in one industry can run quite different businesses, so a peer may not be a close match.
Ratios on different fiscal calendars are not strictly comparable, and a trailing P/E can be distorted by one-time items.
Every fiscal year on this page is reported by one SEC filer, CIK 1049502.
Each figure on this page comes from that filer.
How to read this: understanding investment risk.
Company figures come from the annual reports (Form 10-K) that each company files with the SEC, read from the SEC EDGAR company facts data. The share price and other market data come from a market data provider.
Free cash flow here is operating cash flow minus capital spending. To keep one unusual year from swinging the result, each year is charged with the average of up to five years of capital spending, so the figure is an estimate and not the free cash flow a company reports.
The fair price is the present value of ten years of projected free cash flow plus a terminal value, discounted at 10.1 percent a year, the long-run return of US stocks, with 2.5 percent growth after year ten. The figures on this page are estimates, not advice.
This analysis covers US companies that file 10-K annual reports. Free cash flow describes banks, real estate investment trusts and funds poorly, so treat their figures with extra caution. In the cash returned and balance sheet tables, a value of zero is treated as a gap in the data, not as a real zero.
Read the filings yourself: MKSI annual reports (10-K) on SEC EDGAR. To try your own growth rate, use the intrinsic value calculator on this page. Our editorial standards explain how Trendshare handles its sources and corrections.
Advertisement supports free stock analysis content.
Does MKS Instruments have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.
This example shows how we apply the Trendshare checklist to MKSI: earnings power, cash generation, valuation, and margin of safety.
We check: business quality, free cash flow, P/E, and margin of safety.
Most Popular Articles
What is Dollar Cost Averaging?
Benjamin Graham, Value Investor
How Do Tariffs Affect the Stock Market?
Precious Metals for Value Investors